Japanese NGS Firm Quantum Bio Raises $20M | GenomeWeb

NEW YORK(GenomeWeb) – Japanese next-generation sequencing technology firm Quantum Biosystems has raised Y2.4 billion ($20 million) to continue development of its DNA/RNA sequencer.

The Series B funding comes from new investors Innovation Network Corporation of Japan and Mitsubishi UFJ Capital, as well as existing investors JAFCO, UTEC, and Mizuho Capital, the firm said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.